Evidence map›Paper›PMID 31591695›Full record

ArticleJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology2020

Performance of

Toru Awaya, Ryogo Minamimoto, Kentaro Iwama, Shuji Kubota, Masatoshi Hotta, Risen Hirai, Masaya Yamamoto, Osamu Okazaki, Hisao Hara, Yukio Hiroi and 2 more

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. 2025 Update Consensus ofActa Cardiologica Sinica · 2025
    Article
  3. Review
  4. A Narrative Review ofBiomedicines · 2022
    Review
  5. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2020
    Article
  6. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Toru AwayaDepartment of Cardiovascular Medicine, National Center for Global Health and Medicine, Tokyo, Japan. tooru.awaya@med.toho-u.ac.jp.
Ryogo MinamimotoDivision of Nuclear Medicine, National Center for Global Health and Medicine, Tokyo, Japan.
Kentaro IwamaDepartment of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan.
Shuji KubotaDepartment of Cardiovascular Medicine, National Center for Global Health and Medicine, Tokyo, Japan.
Masatoshi HottaDivision of Nuclear Medicine, National Center for Global Health and Medicine, Tokyo, Japan.
Risen HiraiDepartment of Hematology, Internal medicine Tokyo-Kita Medical Center, Tokyo, Japan.
Masaya YamamotoDepartment of Cardiovascular Medicine, National Center for Global Health and Medicine, Tokyo, Japan.
Osamu OkazakiDepartment of Cardiovascular Medicine, National Center for Global Health and Medicine, Tokyo, Japan.
Hisao HaraDepartment of Cardiovascular Medicine, National Center for Global Health and Medicine, Tokyo, Japan.
Yukio HiroiDepartment of Cardiovascular Medicine, National Center for Global Health and Medicine, Tokyo, Japan.
Michiaki HiroeDepartment of Cardiovascular Medicine, National Center for Global Health and Medicine, Tokyo, Japan.
Masao MoroiDivision of Cardiovascular Medicine, Toho University Medical Center Ohashi Hospital, Tokyo, Japan.
National Center for Global Health and Medicine · JPThe University of Tokyo · JPToho University · JPTokyo-Kita Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLight chain (AL) cardiac amyloidosis is associated with a poor prognosis. Diagnosing at an early stage is critical for treatment and the management of cardiac complication. PURPOSE: We aimed to evaluate the diagnostic performance of METHODS AND

results

conclusions

Indexed as

BiopsyAdultAgedAprotininCardiomyopathiesDefibrillators, ImplantableFemaleHumansImmunoglobulin Light-chain AmyloidosisMaleMiddle AgedMyocardiumNatriuretic Peptide, BrainOrganotechnetium CompoundsPeptide FragmentsProspective StudiesAprotininNatriuretic Peptide, BrainOrganotechnetium CompoundsPeptide Fragmentspro-brain natriuretic peptide (1-76)technetium Tc 99m aprotinin99mTc-aprotinin scintigraphyAL (light chain) cardiac amyloidosisNuclear imaging

Identifiers

PMID31591695
OpenAlexW2979321803

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.